---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-002514"
form_type: "8-K"
ticker: "ERNA"
cik: "0000748592"
company_name: "Ernexa Therapeutics Inc."
filed_at: "2025-04-03T23:59:59+00:00"
generated_at: "2026-05-23T22:57:59.718753+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Eterna Therapeutics raises up to $7.3M in private placement; resets annual meeting to June 2

## Summary
- Initial closing on April 2: sold 9.93M shares and 509,736 pre-funded warrants for $1.1M.
- Second closing of $6.2M (48.33M shares, 10.54M warrants) subject to stockholder approval by June 30 (or July 30 if SEC reviews).
- Purchase price $0.1046 per share; pre-funded warrants at $0.0996 with $0.005 exercise price.
- Investors include existing 32% holder Charles Cherington and former director Nicholas Singer.
- 2025 annual meeting moved to June 2; stockholder proposal deadline is April 13.

## SEC filing metadata
- accession: 0001641172-25-002514
- form_type: 8-K
- ticker: ERNA
- cik: 0000748592
- company_name: Ernexa Therapeutics Inc.
- filed_at: 2025-04-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 5.08, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/748592/000164117225002514/0001641172-25-002514-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/748592/000164117225002514/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-002514
- JSON: https://secwatch.observer/filing/0001641172-25-002514.json
- Plain text: https://secwatch.observer/filing/0001641172-25-002514.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.